نتائج البحث - "Olga Yu. Olisova"

العلاقة: https://www.mimmun.ru/mimmun/article/view/2936/1922Test; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2936/13255Test; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2936/13256Test; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2936/13257Test; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2936/13258Test; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2936/13259Test; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2936/13261Test; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2936/13262Test; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2936/13263Test; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2936/13276Test; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2936/13277Test; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2936/13278Test; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2936/13279Test; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2936/13280Test; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2936/13551Test; Абатуров А.Е., Волосовец А.П., Юлиш Е.И. Участие интерлейкинового семейства 1 в развитии воспалительной реакции при инфекционном процессе. 4. Роль IL-1F11 (il-33) // ЗР. 2014. №5 (56).; Гонсорунова Д.С., Огородова Л. М., Фёдорова О. С., Камалтынова Е. М., Белоногова Е. Г., Кремер Е. Э. Участие Т-регуляторных клеток в иммунном ответе при атопическом дерматите // Бюллетень сибирской медицины. 2011. №4.; Горбачева А.М., Митькин Н. А. Интерлейкин-33: друг или враг в борьбе против опухоли? // МОЛЕКУЛЯРНАЯ БИОЛОГИЯ, 2019, том 53, № 5, с. 774–789.; Дрождина М.Б., Суслова Е.В. Иммунный ответ при атопическом дерматите. Основные патогенетические механизмы и корреляции стадийности в возрастном аспекте. Взаимосвязь с системными процессами дерматологического и недерматологического профиля. Медицинская иммунология. 2021;23(2):237-244.; Кубанов А.А., Намазова-Баранова Л.С., Хаитов Р. М. и др. Федеральные клинические рекомендации: Атопический дерматит, 2020.; Поздеев О.П. "Оценка влияния атопического дерматита на качество жизни пациента" Практическая медицина, no. 1-4 (73), 2013, pp. 112-113.; Трофимова И. Б. Атопический дерматит // Лечебное дело. 2004. №3.; Учасова Е.Г., Груздева О.В., Дылева Ю.А., Каретникова В.Н. «Интерлейкин-33 и фиброз: современный взгляд на патогенез» //Медицинская иммунология, 2018. Т. 20, № 4. С. 477-484.; Шиловский И.П., Дынева М.Е., Курбачева О.М., Кудлай Д.А., Хаитов М.Р. Роль интерлейкина-37 в патогенезе аллергических заболеваний // Acta Naturae (русскоязычная версия). 2019. №4 (43).; Boraschi Diana, Lucchesi Davide, Hainzl Stefan, Leitner Maria, Maier Elisabeth, Mangelberger Doris, Oostingh J. Gertie, Pfaller Tobias, Pixner Claudia, Posselt Gernot, Italiani Paola, Nold F. Marcel, Nold-Petry A. Claudia, Bufler Philip, Dinarello A. Charles. IL-37: a new anti-inflammatory cytokine of the IL-1 family. European Cytokine Network. 2011;22(3):127-147.; Borgia, F.; Custurone, P.; Li Pomi, F.; Vaccaro, M.; Alessandrello, C.; Gangemi, S. IL-33 and IL-37: A Possible Axis in Skin and Allergic Diseases. Int. J. Mol. Sci. 2023, 24, 372.; Cirelli T, Nepomuceno R, Orrico SRP, Rossa C Jr, Cirelli JA, North KE, Graff M, Barros SP, Scarel-Caminaga RM. Validation in a Brazilian population of gene markers of periodontitis previously investigated by GWAS and bioinformatic studies. J Periodontol. 2021 May;92(5):689-703.; Hou, T., Sun, X., Zhu, J., Hon, K. L., Jiang, P., Chu, I. M., Tsang, M. S., Lam, C. W., Zeng, H., & Wong, C. K. (2020). IL-37 Ameliorating Allergic Inflammation in Atopic Dermatitis Through Regulating Microbiota and AMPK-mTOR Signaling Pathway-Modulated Autophagy Mechanism. Frontiers in immunology, 11, 752.; Imai Y. lnterleukin-33 in atopic dermatitis. J Dermatol Sci. 2019;96(1):2-7.; Oboki K., Nakae S., Matsumoto K., Saito H. IL-33 and airway inflammation. Allergy, Asthma Immunol. Res., 2011, Vol. 3, no. 2, pp. 81-88.; Schröder A, Lunding LP, Zissler UM, et al. IL-37 regulates allergic inflammation by counterbalancing pro-inflammatory IL-1 and IL-33. Allergy. 2022;77(3):856-869.; Shi LP, He Y, Liu ZD. Correlation between single nucleotide polymorphism of rs3811047 in IL-1 F7 gene and rheumatoid arthritis susceptibility among Han population in central plains of China. Asian Pac J Trop Med. 2013 Jan;6(1):73-5.; Sullivan GP, Davidovich P, Muñoz-Wolf N, Ward RW, Hernandez Santana YE, Clancy DM, Gorman A, Najda Z, Turk B, Walsh PT, Lavelle EC, Martin SJ. Myeloid cell-derived proteases produce a proinflammatory form of IL-37 that signals via IL-36 receptor engagement. Sci Immunol. 2022 Dec 23;7(78):eade5728.; Tokajian S, Merhi G, Al Khoury C, Nemer G. Interleukin-37: A Link Between COVID-19, Diabetes, and the Black Fungus. Front Microbiol. 2022 Jan 13;12:788741.; Wollenberg, A., Christen-Zäch, S., Taieb, A., Paul, C., Thyssen, J. P., de Bruin-Weller, M., Vestergaard, C., Seneschal, J., Werfel, T., Cork, M. J., Kunz, B., Fölster-Holst, R., Trzeciak, M., Darsow, U., Szalai, Z., Deleuran, M., von Kobyletzki, L., Barbarot, S., Heratizadeh, A., Gieler, U., … European Task Force on Atopic Dermatitis/EADV Eczema Task Force (2020). ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children. Journal of the European Academy of Dermatology and Venereology : JEADV, 34(12), 2717–2744.; Yan N, Meng S, Song RH, Qin Q, Wang X, Yao Q, Jiang Y, Jiang W, Shi L, Xu J, Zhang J. Polymorphism of IL37 gene as a protective factor for autoimmune thyroid disease. J Mol Endocrinol. 2015 Dec;55(3):209-18.; https://www.mimmun.ru/mimmun/article/view/2936Test

الإتاحة: https://doi.org/10.15789/1563-0625-ABP-2936Test
https://doi.org/10.15789/1563-0625-0-0Test
https://www.mimmun.ru/mimmun/article/view/2936Test

View record in BASE

9

دورية أكاديمية

Modern Approaches to the Management of Patients with Urticaria ; Современные подходы к ведению пациентов с крапивницей

المؤلفون: Aleksander A. Baranov, Leyla S. Namazova-Baranova, Natalya I. Il’ina, Alexey A. Kubanov, Elena R. Araviyskaya, Natalya G. Astafieva, Vitaliy T. Bazaev, Elena Yu. Borzova, Elena A. Vishneva, Yulia A. Gallyamova, Inna V. Danilycheva, Olga G. Elisyutina, Ludmila F. Znamenskaya, Vera G. Kalugina, Arphenya E. Karamova, Yulia G. Levina, Raisa Ya. Meshkova, Olga Yu. Olisova, Gennadiy A. Novik, Alexey V. Samtsov, Liliia R. Selimzyanova, Evgeniy V. Sokolovsky, Elena S. Fedenko, Olga S. Fedorova, Daria S. Fomina, Vladislav R. Khayrutdinov, Vadim V. Chikin, Andrey E. Shulzhenko, А. А. Баранов, Л. С. Намазова-Баранова, Н. И. Ильина, А. А. Кубанов, Е. Р. Аравийская, Н. Г. Астафьева, В. Т. Базаев, Е. Ю. Борзова, Е. А. Вишнева, Ю. А. Галлямова, И. В. Данилычева, О. Г. Елисютина, Л. Ф. Знаменская, В. Г. Калугина, А. Е. Карамова, Ю. Г. Левина, Р. Я. Мешкова, О. Ю. Олисова, Г. А. Новик, А. В. Самцов, Л. Р. Селимзянова, Е. В. Соколовский, Е. С. Феденко, О. С. Федорова, Д. С. Фомина, В. Р. Хайрутдинов, В. В. Чикин, А. Е. Шульженко

المساهمون: Not specified, Отсутствует

المصدر: Pediatric pharmacology; Том 20, № 5 (2023); 454-477 ; Педиатрическая фармакология; Том 20, № 5 (2023); 454-477 ; 2500-3089 ; 1727-5776

مصطلحات موضوعية: дети, allergic diseases, diagnosis, treatment, clinical guidelines, children, аллергические болезни, диагностика, лечение, клинические рекомендации

وصف الملف: application/pdf

العلاقة: https://www.pedpharma.ru/jour/article/view/2359/1533Test; Федеральные клинические рекомендации по диагностике и лечению крапивницы. — М.: Российская ассоциация аллергологов и клинических иммунологов; 2015. — 34 с.; Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al. The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2022;77(3):734–766. doi: https://doi.org/10.1111/all.15090Test; Bracken SJ, Abraham S, MacLeod AS. Autoimmune Theories of Chronic Spontaneous Urticaria. Front Immunol. 2019;10:627. doi: https://doi.org/10.3389/fimmu.2019.00627Test; Maurer M, Altrichter S, Schmetzer O, et al. Immunoglobulin E-Mediated Autoimmunity. Front Immunol. 2018;9:689. doi: https://doi.org/10.3389/fimmu.2018.00689Test; Kolkhir P, Church MK, Weller K, et al. Autoimmune chronic spontaneous urticaria: What we know and what we do not know. J Allergy Clin Immunol. 2017;139(6):1772–1781.e1. doi: https://doi.org/10.1016/j.jaci.2016.08.050Test; Vonakis BM, Vasagar K, Gibbons SP Jr, et al. Basophil FcepsilonRI histamine release parallels expression of Src-homology 2-containing inositol phosphatases in chronic idiopathic urticaria. J Allergy Clin Immunol. 2007;119(2):441–448. doi: https://doi.org/10.1016/j.jaci.2006.09.035Test; Luquin E, Kaplan AP, Ferrer M. Increased responsiveness of basophils of patients with chronic urticaria to sera but hypo-responsiveness to other stimuli. Clin Exp Allergy. 2005;35(4):456–460. doi: https://doi.org/10.1111/j.1365-2222.2005.02212.xTest; Gibbs BF, Räthling A, Zillikens D, et al. Initial Fc epsilon RI-mediated signal strength plays a key role in regulating basophil signaling and deactivation. J Allergy Clin Immunol. 2006;118(5):1060–1067. doi: https://doi.org/10.1016/j.jaci.2006.07.022Test; Maurer M, Church MK, Gonçalo M, et al. Management and treatment of chronic urticaria (CU). J Eur Acad Dermatol Venereol. 2015;29(3):16–32. doi: https://doi.org/10.1111/jdv.13198Test; Greenberger PA. Chronic urticaria: new management options. World Allergy Organ J. 2014;7(1):31. doi: https://doi.org/10.1186/1939-4551-7-31Test; Bernstein JA, Lang DM, Khan DA, et al. The diagnosis and management of acute and chronic urticaria: 2014 update. J Allergy Clin Immunol. 2014;133(5):1270–1277. doi: https://doi.org/10.1016/j.jaci.2014.02.036Test; Pite H, Wedi B, Borrego LM, et al. Management of childhood urticaria: current knowledge and practical recommendations. Acta Derm Venereol. 2013;93(5):500–508. doi: https://doi.org/10.2340/00015555-1573Test; Maurer M, Weller K, Bindslev-Jensen C, et al. Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report. Allergy. 2011;66(3):317–330. doi: https://doi.org/10.1111/j.1398-9995.2010.02496.xTest; Fricke J, Ávila G, Keller T, et al. Prevalence of chronic urticaria in children and adults across the globe: Systematic review with meta-analysis. Allergy. 2020;75(2):423–432. doi: https://doi.org/10.1111/all.14037Test; Saini S, Shams M, Bernstein JA, Maurer M. Urticaria and angioedema across the ages. J Allergy Clin Immunol Pract. 2020;8(6):1866–1874. doi: https://doi.org/10.1016/j.jaip.2020.03.0302-6Test; Goldstein S, Gabriel S, Kianifard F, et al. Clinical features of adolescents with chronic idiopathic or spontaneous urticaria: review of omalizumab clinical trials. Ann Allergy Asthma Immunol. 2017;118(4):500–504. doi: https://doi.org/10.1016/j.anai.2017.02.0035Test; Curto-Barredo L, Pujol RM, Roura-Vives G, Gimenez-Arnau AM. Chronic urticaria phenotypes: clinical differences regarding triggers, activity, prognosis and therapeutic response. Eur J Dermatol. 2019;29(6):627–635. doi: https://doi.org/10.1684/ejd.2019.3674Test; Netchiporouk E, Sasseville D, Moreau L, et al. Evaluating comorbidities, natural history, and predictors of early resolution in a cohort of children with chronic urticaria. JAMA Dermatol. 2017;153(12):1236–1242. doi: https://doi.org/10.1001/jamadermatol.2017.3182Test; Kaplan AP. Clinical practice. Chronic urticaria and angioedema. N Engl J Med. 2002;346(3):175–179. doi: https://doi.org/10.1056/NEJMcp011186Test; Caffarelli C, Paravati F, El Hachem M, et al. Management of chronic urticaria in children: a clinical guideline. Ital J Pediatr. 2019;45(1):101. doi: https://doi.org/10.1186/s13052-019-0695-xTest; Toubi E, Kessel A, Avshovich N, et al. Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients. Allergy. 2004;59(8):869–873. doi: https://doi.org/10.1111/j.1398-9995.2004.00473.xTest; Schoepke N, Doumoulakis G, Maurer M. Diagnosis of urticaria. Indian J Dermatol. 2013;58(3):211–218. doi: https://doi.org/10.4103/0019-5154.110831Test; Аллергия у детей: от теории к практике / под ред. Л.С. Намазовой-Барановой. — М.: Союз педиатров России; 2010. — 668 с.; Nettis E, Foti C, Ambrifi M, et al. Urticaria: recommendations from the Italian Society of Allergology, Asthma and Clinical Immunology and the Italian Society of Allergological, Occupational and Environmental Dermatology. Clin Mol Allergy. 2020;18:8. doi: https://doi.org/10.1186/s12948-020-00123-8Test; Metz M, Altrichter S, Buttgereit T, et al. The Diagnostic Workup in Chronic Spontaneous Urticaria-What to Test and Why. J Allergy Clin Immunol Pract. 2021;9(6):2274–2283. doi: https://doi.org/10.1016/j.jaip.2021.03.049Test; Kolkhir P, André F, Church MK, et al. Potential blood biomarkers in chronic spontaneous urticaria. Clin Exp Allergy. 2017;47(1):19–36. doi: https://doi.org/10.1111/cea.12870Test; Altrichter S, Fok JS, Jiao Q, et al. Total IgE as a Marker for Chronic Spontaneous Urticaria. Allergy Asthma Immunol Res. 2021;13(2):206–218. doi: https://doi.org/10.4168/aair.2021.13.2.206Test; Fok JS, Kolkhir P, Church MK, Maurer M. Predictors of treatment response in chronic spontaneous urticaria. Allergy. 2021;76(10):2965–2981. doi: https://doi.org/10.1111/all.14757Test; Kolkhir P, Altrichter S, Asero R, et al. Autoimmune Diseases Are Linked to Type IIb Autoimmune Chronic Spontaneous Urticaria. Allergy Asthma Immunol Res. 2021;13(4):545–559. doi: https://doi.org/10.4168/aair.2021.13.4.545Test; Cornillier H, Giraudeau B, Munck S, et al. Chronic spontaneous urticaria in children — a systematic review on interventions and comorbidities. Pediatr Allergy Immunol. 2018;29(3):303–310. doi: https://doi.org/10.1111/pai.12870Test; Spickett G. Urticaria and angioedema. J R Coll Physicians Edinb. 2014;44(1):50–54. doi: https://doi.org/10.4997/JRCPE.2014.112Test; Kolkhir P, Balakirski G, Merk HF, et al. Chronic spontaneous urticaria and internal parasites--a systematic review. Allergy. 2016;71(3):308–322. doi: https://doi.org/10.1111/all.12818Test; Minciullo PL, Cascio A, Gangemi S. Association between urticaria and nematode infections. Allergy Asthma Proc. 2018;39(2):86–95. doi: https://doi.org/10.2500/aap.2018.38.4104Test; Fedorova OS, Fedotova MM, Zvonareva OI, et al. Opisthorchis felineus infection, risks, and morbidity in rural Western Siberia, Russian Federation. PLoS Negl Trop Dis. 2020;14(6):e0008421. doi: https://doi.org/10.1371/journal.pntd.0008421Test; Sayasone S, Odermatt P, Phoumindr N, et al. Epidemiology of Opisthorchis viverrini in a rural district of southern Lao PDR. Trans R Soc Trop Med Hyg. 2007;101(1):40–47. doi: https://doi.org/10.1016/j.trstmh.2006.02.018Test; Neumayr A. Antiparasitic treatment recommendations: A practical guide to clinical parasitology. Hamburg: Tredition GmbH; 2016. 173 p.; Ataseven A, Durmaz K, Ozer I, Dursun R. Gallstones at chronic spontaneous urticaria patients: A retrospective clinical study. Dermatol Ther. 2020;33(2):e13212. doi: https://doi.org/10.1111/dth.13212Test; Minciullo PL, Cascio A, Barberi G, Gangemi S. Urticaria and bacterial infections. Allergy Asthma Proc. 2014;35(4):295–302. doi: https://doi.org/10.2500/aap.2014.35.3764Test; Imbalzano E, Casciaro M, Quartuccio S, et al. Association between urticaria and virus infections: A systematic review. Allergy Asthma Proc. 2016;37(1):18–22. doi: https://doi.org/10.2500/aap.2016.37.3915Test; Sugrañes-Montalván A, Barreto-Suárez E, Nicolau-Pestana E, Quesada-Leyva L. Relación entre infección por Helicobacter pylori y urticaria crónica. Rev Alerg Mex. 2017;64(4):396–402. doi: https://doi.org/10.29262/ram.v64i4.283Test; Kim HJ, Kim YJ, Lee HJ, et al. Systematic review and metaanalysis: Effect of Helicobacter pylori eradication on chronic spontaneous urticaria. Helicobacter. 2019;24(6):e12661. doi: https://doi.org/10.1111/hel.12661Test; Maurer M, Magerl M, Ansotegui I, et al. The international WAO/ EAACI guideline for the management of hereditary angioedema-The 2017 revision and update. Allergy. 2018;73(8):1575–1596. doi: https://doi.org/10.1111/all.13384Test; Caballero T, Baeza ML, Cabañas R, et al. Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part II. Treatment, follow-up, and special situations. J Investig Allergol Clin Immunol. 2011;21(6):422–441; quiz 442–443.; Cicardi M, Aberer W, Banerji A, et al. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. Allergy. 2014;69(5):602–616. doi: https://doi.org/10.1111/all.12380Test; Bowen T, Cicardi M, Farkas H, et al. 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol. 2010;6(1):24. doi: https://doi.org/10.1186/1710-1492-6-24Test; Agostoni A, Aygören-Pürsün E, Binkley KE, et al. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol. 2004;114(3 Suppl):S51–S131. doi: https://doi.org/10.1016/j.jaci.2004.06.047Test; Peroni A, Colato C, Schena D, Girolomoni G. Urticarial lesions: if not urticaria, what else? The differential diagnosis of urticaria: part 1. Cutaneous diseases. J Am Acad Dermatol. 2010;62:541–555. doi: https://doi.org/10.1016/j.jaad.2009.11.686Test; Niu XL, Zhu LL, Shi MH, et al. Association of positive and negative autologous serum skin test responses with clinical features of chronic spontaneous urticaria in Asian patients: A systematic review and meta-analysis. Exp Ther Med. 2019;17(4):2603–2613. doi: https://doi.org/10.3892/etm.2019.7266Test; Kulthanan K, Subchookul C, Hunnangkul S, et al. Factors Predicting the Response to Cyclosporin Treatment in Patients With Chronic Spontaneous Urticaria: A Systematic Review. Allergy Asthma Immunol Res. 2019;11(5):736–755. doi: https://doi.org/10.4168/aair.2019.11.5.736Test; George M, Balachandran C, Prabhu S. Chronic idiopathic urticaria: comparison of clinical features with positive autologous serum skin test. Indian J Dermatol Venereol Leprol. 2008;74(2):105–108. doi: https://doi.org/10.4103/0378-6323.39690Test; Khan DA. Chronic spontaneous urticaria: Standard management and patient education. In: UpToDate. Last updated: Apr 26, 2022. Available online: https://www.uptodate.com/contents/chronicspontaneous-urticaria-standard-management-and-patient-educatioTest n?search=urticaria&source=search_result&selectedTitle=2~150&usage_type=default&display_rank=2. Accessed on September 30, 2023.; Cicardi M, Bellis P, Bertazzoni G, et al. Guidance for diagnosis and treatment of acute angioedema in the emergency department: consensus statement by a panel of Italian experts. Intern Emerg Med. 2014;9(1):85–92. doi: https://doi.org/10.1007/s11739-013-0993-zTest; Depetri F, Tedeschi A, Cugno M. Angioedema and emergency medicine: From pathophysiology to diagnosis and treatment. Eur J Intern Med. 2019;59:8–13. doi: https://doi.org/10.1016/j.ejim.2018.09.004Test; Adeyeni TA, Domack A, Britt C. What Is the Role of Laryngoscopy in Angioedema Isolated to the Lips, Without Laryngeal Symptoms? Laryngoscope. 2020;130(12):2740–2741. doi: https://doi.org/10.1002/lary.28664Test; Weller K, Groffik A, Magerl M, et al. Development, validation, and initial results of the Angioedema Activity Score. Allergy. 2013;68(9):1185–1192. doi: https://doi.org/10.1111/all.12209Test; Shikiar R, Harding G, Leahy M, Lennox RD. Minimal important difference (MID) of the Dermatology Life Quality Index (DLQI): results from patients with chronic idiopathic urticaria. Health Qual Life Outcomes. 2005;3:36. doi: https://doi.org/10.1186/1477-7525-3-36Test; Prosty C, Gabrielli S, Mule P, et al. Validation of the Urticaria Control Test (UCT) in Children With Chronic Urticaria. J Allergy Clin Immunol Pract. 2022;10(12):3293–3298.e2. doi: https://doi.org/10.1016/j.jaip.2022.07.037Test; Młynek A, Zalewska-Janowska A, Martus P, et al. How to assess disease activity in patients with chronic urticaria? Allergy. 2008;63(6):777–780. doi: https://doi.org/10.1111/j.1398-9995.2008.01726.xTest; Patruno C, Napolitano M, Ferrucci S, et al. Four-week Urticaria Activity Score-7 as a Useful Patient-reported Outcome to Assess Chronic Spontaneous Urticaria: A Multicentre Study Evaluation of Adherence and Patients’ Perspective. Acta Derm Venereol. 2019;99(10):903–904. doi: https://doi.org/10.2340/00015555-3231Test; Борзова Е.Ю., Салугина C.О. Актуальные вопросы дифференциальной диагностики крапивницы // Эффективная фармакотерапия. Аллергология и иммунология. — 2017. — Т. 7. — № 1. — С. 34–44.; Soter NA. Chronic urticaria as a manifestation of necrotizing venulitis. N Engl J Med. 1977;296(25):1440–1442. doi: https://doi.org/10.1056/NEJM197706232962505Test; Данилычева И.В., Борзова Е.Ю., Ильина Н.И. Уртикарный васкулит. От диагностики к лечению // Российский аллергологический журнал. — 2012. — Т. 5. — № 1. — С. 71–76.; Brodell LA, Beck LA. Differential diagnosis of chronic urticaria. Ann Allergy Asthma Immunol. 2008;100(3):181–215. doi: https://doi.org/10.1016/S1081-1206Test(10)60438-3; Махнева Н.В. Современный взгляд на диагностику и лечение буллезных дерматозов // Международный журнал прикладных и фундаментальных исследований. — 2011. — № 9. — С. 15–17.; Банченко Г.В., Флейшер Г.М., Горин А.А. Опыт лечения многоформной экссудативной эритемы // Медицинский алфавит. — 2013. — Т. 1. — № 1. — С. 44–46.; Patel S, Patel R, Draikiwicz S, Capitle E. Peripheral T-cell lymphoma: a challenging mimicker of angioedema and urticaria. Ann Allergy Asthma Immunol. 2015;115(2):94–95. doi: https://doi.org/10.1016/j.anai.2015.06.013Test; Brockow K. Urticaria pigmentosa. Immunol Allergy Clin North Am. 2004;24(2):287-vii. doi: https://doi.org/10.1016/j.iac.2004.01.002Test; Халиулин Ю.Г. Мастоцитоз: клинические проявления, методы диагностики и тактика ведения пациентов // Лечащий врач. — 2012. — № 8. — С. 83–89.; Мухин Н., Моисеев C., Попова Е. и др. Поздние проявления Лаймской болезни // Врач. — 2006. — № 5. — С. 35–38.; Кочергин Н., Никитина Е., Цыкин А. Некоторые особенности дерматозов беременных // Врач. — 2010. — № 1. — С. 51–55.; Новиков Д.К., Сергеев Ю.В., Новиков П.Д., Сергеев А.Ю. Побочные аллергические реакции на медикаменты в дерматологии // Иммунопатология, аллергология и инфектология. — 2003. — № 3. — С. 45–67. — doi: https://doi.org/10.14427/jipai.2018.3.60Test; Foer D, Buchheit KM, Gargiulo AR, et al. Progestogen Hypersensitivity in 24 Cases: Diagnosis, Management, and Proposed Renaming and Classification. J Allergy Clin Immunol Pract. 2016;4(4):723–729. doi: https://doi.org/10.1016/j.jaip.2016.03.003Test; Антонова О.В., Трофимов П.Н., Белоусова И.Э., Самцов А.В. Ретикулярный эритематозный муциноз // Вестник дерматологии и венерологии. — 2014. — № 5. — С. 96–99.; Kolkhir P, Pogorelov D, Olisova O, Maurer M. Comorbidity and pathogenic links of chronic spontaneous urticaria and systemic lupus erythematosus — a systematic review. Clin Exp Allergy. 2016;46(2):275–287. doi: https://doi.org/10.1111/cea.12673Test; Кузьмина Н.Н., Салугина C.О., Федоров E.C. Аутовоспалительные заболевания и синдромы у детей: учебно-методическое пособие. М.: ИМА-ПРЕСС; 2012.; Barron K, Athreya B, Kastner D. Periodic fever syndromes and other inherited autoinflammatory diseases. In: Textbook of pediatric rheumatology. Cassidy JT, Petty RE, eds. 7th ed. Elsevier Saunders; 2015. pp. 609–641.; Toplak N, Frenkel J, Ozen S, et al. An international registry on autoinflammatory diseases: the Eurofever experience. Ann Rheum Dis. 2012;71(7):1177–1182. doi: https://doi.org/10.1136/annrheumdis-2011-200549Test; Simon A, Asli B, Braun-Falco M, et al. Schnitzler’s syndrome: diagnosis, treatment, and follow-up. Allergy. 2013;68(5):562–568. doi: https://doi.org/10.1111/all.12129Test; De Castro FR, Masouye I, Winkelmann RK, Saurat JH. Urticarial pathology in Schnitzler’s (hyper-IgM) syndrome. Dermatology. 1996;193(2):94–99.; Знаменская Л.Ф., Осокина Д.Е., Вавилов А.М. Синдром Свита // Вестник дерматологии и венерологии. — 2008. — № 2. — С. 94–96.; Butterfield JH. Flushing and urticarial syndromes presenting as anaphylaxis. In: Anaphylaxis and hypersensitivity reactions. Castells M, ed. Springer; 2010. pp. 271–284.; Хегер П.Г. Детская дерматология: дифференциальная диагностика и лечение у детей и подростков. — М.: Издательство Панфилова; 2013. — 634 с.; Аллергология и иммунология: практические рекомендации для педиатров / под ред. Л.С. Намазовой-Барановой, А.А. Баранова, Р.М. Хаитова. — М.: ПедиатрЪ; 2020. — 512 с.; Hocqueloux L, Guinard J, Buret J, et al. Do penicillins really increase the frequency of a rash when given during Epstein-Barr Virus primary infection? Clin Infect Dis. 2013;57(11):1661–1662. doi: https://doi.org/10.1093/cid/cit553Test; Dibek Misirlioglu E, Guvenir H, Ozkaya Parlakay A, et al. Incidence of Antibiotic-Related Rash in Children with Epstein-Barr Virus Infection and Evaluation of the Frequency of Confirmed Antibiotic Hypersensitivity. Int Arch Allergy Immunol. 2018;176(1):33–38. doi: https://doi.org/10.1159/000481988Test; Kowalski ML, Woessner K, Sanak M. Approaches to the diagnosis and management of patients with a history of nonsteroidal antiinflammatory drug-related urticaria and angioedema. J Allergy Clin Immunol. 2015;136(2):245–251. doi: https://doi.org/10.1016/j.jaci.2015.06.021Test; Shakouri A, Compalati E, Lang DM, Khan DA. Effectiveness of Helicobacter pylori eradication in chronic urticaria: evidence-based analysis using the Grading of Recommendations Assessment, Development, and Evaluation system. Curr Opin Allergy Clin Immunol. 2010;10(4):362–369. doi: https://doi.org/10.1097/ACI.0b013e32833c79d7Test; Ishaq S, Nunn L. Helicobacter pylori and gastric cancer: a state of the art review. Gastroenerol Hepatol Bed Bench. 2015;8(Suppl 1):S6–S14.; Arik Yilmaz E, Karaatmaca B, Sackesen C, et al. Parasitic Infections in Children with Chronic Spontaneous Urticaria. Int Arch Allergy Immunol. 2016;171(2):130–135. doi: https://doi.org/10.1159/000450953Test; Zuberbier T, Chantraine Kess S, Hartmann K, Czarnetzki BM. Pseudoallergen-free diet in the treatment of chronic urticaria — a prospective study. Acta Derm Venereol. 1995;75(6):484–487. doi: https://doi.org/10.2340/0001555575484487Test; Cornillier H, Giraudeau B, Samimi M, et al. Effect of Diet in Chronic Spontaneous Urticaria: A Systematic Review. Acta Derm Venereol. 2019;99(2):127–132. doi: https://doi.org/10.2340/00015555-3015Test; Nettis E, Colanardi MC, Ferrannini A, Tursi A. Sodium benzoateinduced repeated episodes of acute urticaria/angio-oedema: randomized controlled trial. Br J Dermatol. 2004;151(4):898–902. doi: https://doi.org/10.1111/j.1365-2133.2004.06095.xTest; Akoglu G, Atakan N, Cakır B, et al. Effects of low pseudoallergen diet on urticarial activity and leukotriene levels in chronic urticaria. Arch Dermatol Res. 2012;304(4):257–262. doi: https://doi.org/10.1007/s00403-011-1203-3Test; Son JH, Chung BY, Kim HO, Park CW. A Histamine-Free Diet Is Helpful for Treatment of Adult Patients with Chronic Spontaneous Urticaria. Ann Dermatol. 2018;30(2):164–172. doi: https://doi.org/10.5021/ad.2018.30.2.164Test; Sánchez-Pérez S, Comas-Basté O, Veciana-Nogués MT, et al. Low-Histamine Diets: Is the Exclusion of Foods Justified by Their Histamine Content? Nutrients. 2021;13(5):1395. doi: https://doi.org/10.3390/nu13051395Test; Аллергология: федеральные клинические рекомендации / под ред. Р.М. Хаитова, Н.И. Ильина. — М.: Фармарус Принт медиа; 2014. — 126 с.; Beissert S, Ständer H, Schwarz T. UVA rush hardening for the treatment of solar urticaria. J Am Acad Dermatol. 2000;42(6):1030–1032. doi: https://doi.org/10.1016/s0190-9622Test(00)90299-8; Kring Tannert L, Stahl Skov P, Bjerremann Jensen L, et al. Cold urticaria patients exhibit normal skin levels of functional mast cells and histamine after tolerance induction. Dermatology. 2012;224(2):101–105. doi: https://doi.org/10.1159/000336572Test; Sharma M, Bennett C, Cohen SN, Carter B. H1-antihistamines for chronic spontaneous urticaria. Cochrane Database Syst Rev. 2014;2014(11):CD006137. doi: https://doi.org/10.1002/14651858.CD006137Test; Williams PV. Pharmacologic Management of Chronic Urticaria in Pediatric Patients: The Gap Between Guidelines and Practice. Paediatr Drugs. 2020;22(1):21–28. doi: https://doi.org/10.1007/s40272-019-00365-3Test; Kudryavtseva AV, Neskorodova KA, Staubach P. Urticaria in children and adolescents: An updated review of the pathogenesis and management. Pediatr Allergy Immunol. 2019;30(1):17–24. doi: https://doi.org/10.1111/pai.12967Test; Nakamura T, Hiraoka K, Harada R, et al. Brain histamine H1 receptor occupancy after oral administration of desloratadine and loratadine. Pharmacol Res Perspect. 2019;7(4):e00499. doi: https://doi.org/10.1002/prp2.499Test; Haria M, Fitton A, Peters DH. Loratadine. A reappraisal of its pharmacological properties and therapeutic use in allergic disorders. Drugs. 1994;48(4):617–637. doi: https://doi.org/10.2165/00003495-199448040-00009Test; Zuraw B. An overview of angioedema: Clinical features, diagnosis, and management. In: UpToDate. Last updated: Sep 17, 2023. Available online: https://www.uptodate.com/contents/an-overview-of-angioedema-clinical-features-diagnosis-and-managementTest? search=urticaria&topicRef=8108&source=related_link. Accessed on October 01, 2023.; Анафилактический шок: федеральные клинические рекомендации / Российская ассоциация аллергологов и клинических иммунологов; Федерация анестезиологов и реаниматологов. — М.; 2022.; Zuberbier T, Iffländer J, Semmler C, Henz BM. Acute urticaria: clinical aspects and therapeutic responsiveness. Acta Derm Venereol. 1996;76(4):295–297. doi: https://doi.org/10.2340/0001555576295297Test; Asero R, Tedeschi A. Usefulness of a short course of oral prednisone in antihistamine-resistant chronic urticaria: a retrospective analysis. J Investig Allergol Clin Immunol. 2010;20(5):386–390.; Talarico V, Marseglia GL, Lanari M, et al. Pediatric urticaria in the Emergency Department: epidemiological characteristics and predictive factors for its persistence in children. Eur Ann Allergy Clin Immunol. 2021;53(2):80–85. doi: https://doi.org/10.23822/EurAnnACI.1764-1489.148Test; Long BJ, Koyfman A, Gottlieb M. Evaluation and Management of Angioedema in the Emergency Department. West J Emerg Med. 2019;20(4):587–600. doi: https://doi.org/10.5811/westjem.2019.5.42650Test; Agache I, Rocha C, Pereira A, et al. Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria: A systematic review for the EAACI Biologicals Guidelines. Allergy. 2021;76(1):59–70. doi: https://doi.org/10.1111/all.14547Test; Aleksandraviciute L, Malinauskiene L, Cerniauskas K, Chomiciene A. Plasmapheresis: Is it a potential alternative treatment for chronic urticaria? Open Med (Wars). 2021;17(1):113–118. doi: https://doi.org/10.1515/med-2021-0399Test; Altrichter S, Salow J, Ardelean E, et al. Development of a standardized pulse-controlled ergometry test for diagnosing and investigating cholinergic urticaria. J Dermatol Sci. 2014;75(2):88–93. doi: https://doi.org/10.1016/j.jdermsci.2014.04.007Test; Lee EE, Maibach HI. Treatment of urticaria. An evidence-based evaluation of antihistamines. Am J Clin Dermatol. 2001;2(1):27–32. doi: https://doi.org/10.2165/00128071-200102010-00005Test; Grob JJ, Auquier P, Dreyfus I, Ortonne JP. How to prescribe antihistamines for chronic idiopathic urticaria: desloratadine daily vs PRN and quality of life. Allergy. 2009;64(4):605–612. doi: https://doi.org/10.1111/j.1398-9995.2008.01913.xTest; Weller K, Ardelean E, Scholz E, et al. Can On-demand Nonsedating Antihistamines Improve Urticaria Symptoms? A Doubleblind, Randomized, Single-dose Study. Acta Derm Venereol. 2013;93(2):168–174. doi: https://doi.org/10.2340/00015555-1434Test; Murota H, Kitaba S, Tani M, et al. Impact of sedative and non-sedative antihistamines on the impaired productivity and quality of life in patients with pruritic skin diseases. Allergol Int. 2010;59(4):345–354. doi: https://doi.org/10.2332/allergolint.10-OA-0182Test; Fein MN, Fischer DA, O’Keefe AW, Sussman GL. CSACI position statement: newer generation H1-antihistamines are safer than first-generation H1-antihistamines and should be the first-line antihistamines for the treatment of allergic rhinitis and urticaria. Allergy Asthma Clin Immunol. 2019;15:61. doi: https://doi.org/10.1186/s13223-019-0375-9Test; Chu DK, Oykhman P, Sussman GL. How to use antihistamines. CMAJ. 2021;193(14):E478–E479. doi: https://doi.org/10.1503/cmaj.201959Test; Staevska M, Popov TA, Kralimarkova T, et al. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria. J Allergy Clin Immunol. 2010;125(3):676–682. doi: https://doi.org/10.1016/j.jaci.2009.11.047Test; Siebenhaar F, Degener F, Zuberbier T, et al. High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. J Allergy Clin Immunol. 2009;123(3):672–679. doi: https://doi.org/10.1016/j.jaci.2008.12.008Test; Giménez-Arnau A, Izquierdo I, Maurer M. The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo-controlled treatment with rupatadine 10 and 20 mg. J Eur Acad Dermatol Venereol. 2009;23(9):1088–1091. doi: https://doi.org/10.1111/j.1468-3083.2009.03289.xTest; Phinyo P, Koompawichit P, Nochaiwong S, et al. Comparative Efficacy and Acceptability of Licensed Dose Second-Generation Antihistamines in Chronic Spontaneous Urticaria: A Network Meta-Analysis. J Allergy Clin Immunol Pract. 2021;9(2):956–970.e57. doi: https://doi.org/10.1016/j.jaip.2020.08.055Test; Iriarte Sotés P, Armisén M, Usero-Bárcena T, et al. Efficacy and Safety of Up-dosing Antihistamines in Chronic Spontaneous Urticaria: A Systematic Review of the Literature. J Investig Allergol Clin Immunol. 2021;31(4):282–291. doi: https://doi.org/10.18176/jiaci.0649Test; Guillén-Aguinaga S, Jáuregui Presa I, Aguinaga-Ontoso E, et al. Updosing nonsedating antihistamines in patients with chronic spontaneous urticaria: a systematic review and meta-analysis. Br J Dermatol. 2016;175(6):1153–1165. doi: https://doi.org/10.1111/bjd.14768Test; Church MK, Tiongco-Recto M, Ridolo E, Novák Z. Bilastine: a lifetime companion for the treatment of allergies. Curr Med Res Opin. 2020;36(3):445–454. doi: https://doi.org/10.1080/03007995.2019.1681134Test; Kontou-Fili K, Maniatakou G, Demaka P, et al. Therapeutic effects of cetirizine in delayed pressure urticaria: clinicopathologic findings. J Am Acad Dermatol. 1991;24(6 Pt 2):1090–1093. doi: https://doi.org/10.1016/0190-9622Test(91)70163-v; Zuberbier T, Münzberger C, Haustein U, et al. Doubleblind crossover study of high-dose cetirizine in cholinergic urticaria. Dermatology. 1996;193(4):324–327. doi: https://doi.org/10.1159/000246281Test; Zhang L, Wu J, Qi Y, et al. Long-term combinations and updosing of second-generation H1-antihistamines show efficacy and safety in the treatment of chronic spontaneous urticaria: A multicenter reallife pilot study. J Allergy Clin Immunol Pract. 2020;8(5):1733–1736. e11. doi: https://doi.org/10.1016/j.jaip.2019.12.006Test; Sarti L, Barni S, Giovannini M, et al. Efficacy and tolerability of the updosing of second-generation non-sedating H1 antihistamines in children with chronic spontaneous urticaria. Pediatr Allergy Immunol. 2021;32(1):153–160. doi: https://doi.org/10.1111/pai.13325Test; Koosakulchai V, Yuenyongviwat A, Sangsupawanich P. Risk factors of uncontrolled symptoms using the standard dose of secondgeneration H1-antihistamines in chronic spontaneous urticaria children. Asian Pac J Allergy Immunol. 2022;40(2):121–125. doi: https://doi.org/10.12932/AP-030619-0573Test; Zhao ZT, Ji CM, Yu WJ, et al. Omalizumab for the treatment of chronic spontaneous urticaria: A meta-analysis of randomized clinical trials. J Allergy Clin Immunol. 2016;137(6):1742–1750.e4. doi: https://doi.org/10.1016/j.jaci.2015.12.1342Test; Maurer M, Metz M, Brehler R, et al. Omalizumab treatment in patients with chronic inducible urticaria: A systematic review of published evidence. J Allergy Clin Immunol. 2018;141(2):638–649. doi: https://doi.org/10.1016/j.jaci.2017.06.032Test; Tharp MD, Bernstein JA, Kavati A, et al. Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria: A Meta-analysis of “Real-world” Evidence. JAMA Dermatol. 2019;155(1):29–38. doi: https://doi.org/10.1001/jamadermatol.2018.3447Test; Saini S, Rosen KE, Hsieh HJ, et al. A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria. J Allergy Clin Immunol. 2011;128(3):567–573.e1. doi: https://doi.org/10.1016/j.jaci.2011.06.010Test; Maurer M, Altrichter S, Bieber T, et al. Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase. J Allergy Clin Immunol. 2011;128(1):202–209.e5. doi: https://doi.org/10.1016/j.jaci.2011.04.038Test; Saini SS, Bindslev-Jensen C, Maurer M, et al. Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H1 antihistamines: a randomized, placebo-controlled study. J Invest Dermatol. 2015;135(1):67–75. doi: https://doi.org/10.1038/jid.2014.306Test; Maurer M, Rosén K, Hsieh HJ, et al. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. N Engl J Med. 2013;368(10):924–935. doi: https://doi.org/10.1056Test/ NEJMoa1215372; Kaplan A, Ledford D, Ashby M, et al. Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy. J Allergy Clin Immunol. 2013;132(1):101–109. doi:10.1016/j.jaci.2013.05.013; Urgert MC, van den Elzen MT, Knulst AC, et al. Omalizumab in patients with chronic spontaneous urticaria: a systematic review and GRADE assessment. Br J Dermatol. 2015;173(2):404–415. doi: https://doi.org/10.1111/bjd.13845Test; Rubini NPM, Ensina LFC, Silva EMK, et al. Effectiveness and safety of Omalizumab in the treatment of chronic spontaneous urticaria: Systematic review and meta-analysis. Allergol Immunopathol (Madr). 2019;47(6):515–522. doi: https://doi.org/10.1016/j.aller.2019.05.003Test; Jia HX, He YL. Efficacy and Safety of Omalizumab for Chronic Spontaneous Urticaria: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Am J Ther. 2020;27(5):e455–e467. doi: https://doi.org/10.1097/MJT.0000000000000912Test; Summary of Product Characteristics — Xolair (omalizumab). Available online: https://www.ema.europa.eu/en/documents/product-information/xolair-epar-product-information_en.pdfTest. Accessed on October 01, 2023.; Kocatürk E, Deza G, Kızıltaç K, Giménez-Arnau AM. Omalizumab Updosing for Better Disease Control in Chronic Spontaneous Urticaria Patients. Int Arch Allergy Immunol. 2018;177(4):360–364. doi: https://doi.org/10.1159/000491530Test; Metz M, Vadasz Z, Kocatürk E, Giménez-Arnau AM. Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence. Clin Rev Allergy Immunol. 2020;59(1):38–45. doi: https://doi.org/10.1007/s12016-020-08794-6Test; Manzoor H, Razi F, Rasheed A, et al. Efficacy of Different Dosing Regimens of IgE Targeted Biologic Omalizumab for Chronic Spontaneous Urticaria in Adult and Pediatric Populations: A Meta-Analysis. Healthcare (Basel). 2022;10(12):2579. doi: https://doi.org/10.3390/healthcare10122579Test; Staubach P, Peveling-Oberhag A, Lang BM, et al. Severe chronic spontaneous urticaria in children — treatment options according to the guidelines and beyond — a 10 years review. J Dermatolog Treat. 2022;33(2):1119–1122. doi: https://doi.org/10.1080/09546634.2020.1782326Test; Stellato C, de Paulis A, Ciccarelli A, et al. Anti-inflammatory effect of cyclosporin A on human skin mast cells. J Invest Dermatol. 1992;98(5):800–804. doi: https://doi.org/10.1111/1523-1747.ep12499960Test; Harrison CA, Bastan R, Peirce MJ, et al. Role of calcineurin in the regulation of human lung mast cell and basophil function by cyclosporine and FK506. Br J Pharmacol. 2007;150(4):509–518. doi: https://doi.org/10.1038/sj.bjp.0707002Test; Boubouka CD, Charissi C, Kouimintzis D, et al. Treatment of autoimmune urticaria with low-dose cyclosporin A: A one-year follow-up. Acta Derm Venereol. 2011;91(1):50–54. doi: https://doi.org/10.2340/00015555-0939Test; Grattan CE, O’Donnell BF, Francis DM, et al. Randomized double-blind study of cyclosporin in chronic ‘idiopathic’ urticaria. Br J Dermatol. 2000;143(2):365–372. doi: https://doi.org/10.1046/j.1365-2133.2000.03664.xTest; Vena GA, Cassano N, Colombo D, et al. Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial. J Am Acad Dermatol. 2006;55(4):705–709. doi: https://doi.org/10.1016/j.jaad.2006.04.078Test; Kulthanan K, Chaweekulrat P, Komoltri C, et al. Cyclosporine for Chronic Spontaneous Urticaria: A Meta-Analysis and Systematic Review. J Allergy Clin Immunol Pract. 2018;6(2):586–599. doi: https://doi.org/10.1016/j.jaip.2017.07.017Test; Doshi DR, Weinberger MM. Experience with cyclosporine in children with chronic idiopathic urticaria. Pediatr Dermatol. 2009;26(4):409–413. doi: https://doi.org/10.1111/j.1525-1470.2009.00869.xTest; Sánchez J, Alvarez L, Cardona R. Cyclosporine and omalizumab together: A new option for chronic refractory urticaria. J Allergy Clin Immunol Pract. 2020;8(6):2101–2103. doi: https://doi.org/10.1016/j.jaip.2020.02.012Test; Rosenblum JD, Nassau S, Fonacier L, Mawhirt SL. Concomitant treatment with omalizumab and cyclosporine for chronic spontaneous urticaria. Ann Allergy Asthma Immunol. 2020;125(1):111–112. doi: https://doi.org/10.1016/j.anai.2020.04.020Test; Mitchell S, Balp MM, Samuel M, et al. Systematic review of treatments for chronic spontaneous urticaria with inadequate response to licensed first-line treatments. Int J Dermatol. 2015;54(9):1088–1104. doi: https://doi.org/10.1111/ijd.12727Test; Ryan C, Amor KT, Menter A. The use of cyclosporine in dermatology: part II. J Am Acad Dermatol. 2010;63(6):949–974. doi: https://doi.org/10.1016/j.jaad.2010.02.062Test; Vena GA, Cassano N, D’Argento V, Milani M. Clobetasol propionate 0.05% in a novel foam formulation is safe and effective in the short-term treatment of patients with delayed pressure urticaria: a randomized, double-blind, placebo-controlled trial. Br J Dermatol. 2006;154(2):353–356. doi: https://doi.org/10.1111/j.1365-2133.2005.06986.xTest; Kozel MMA, Sabroe RA. Chronic urticaria: aetiology, management and current and future treatment options. Drugs. 2004;64(22):2515–2536. doi: https://doi.org/10.2165/00003495-200464220-00003Test; Barlow RJ, Macdonald DM, Black AK, Greaves MW. The effects of topical corticosteroids on delayed pressure urticaria. Arch Dermatol Res. 1995;287(3-4):285–288. doi: https://doi.org/10.1007/BF01105080Test; Holm JG, Ivyanskiy I, Thomsen SF. Use of nonbiologic treatments in antihistamine-refractory chronic urticaria: a review of published evidence. J Dermatolog Treat. 2018;29(1):80–97. doi: https://doi.org/10.1080/09546634.2017.1329505Test; Morgan M, Cooke A, Rogers L, et al. Double-blind placebocontrolled trial of dapsone in antihistamine refractory chronic idiopathic urticaria. J Allergy Clin Immunol Pract. 2014;2(5):601–606. doi: https://doi.org/10.1016/j.jaip.2014.06.004Test; Alkeraye S, AlRuhaimi DK. The Addition of Montelukast for the Treatment of Chronic Idiopathic Urticaria. Cureus. 2021;13(7):e16137. doi: https://doi.org/10.7759/cureus.16137Test; Akenroye AT, McEwan C, Saini SS. Montelukast reduces symptom severity and frequency in patients with angioedemapredominant chronic spontaneous urticaria. J Allergy Clin Immunol Pract. 2018;6(4):1403–1405. doi: https://doi.org/10.1016/j.jaip.2018.04.026Test; Grattan CE, Francis DM, Slater NG, et al. Plasmapheresis for severe, unremitting, chronic urticaria. Lancet. 1992;339(8801):1078–1080. doi: https://doi.org/10.1016/0140-6736Test(92)90666-q; Etwel F, Faught LH, Rieder MJ, Koren G. The Risk of Adverse Pregnancy Outcome After First Trimester Exposure to H1 Antihistamines: A Systematic Review and Meta-Analysis. Drug Saf. 2017;40(2):121–132. doi: https://doi.org/10.1007/s40264-016-0479-9Test; Gonzalez-Estrada A, Geraci SA. Allergy Medications During Pregnancy. Am J Med Sci. 2016;352(3):326–331. doi: https://doi.org/10.1016/j.amjms.2016.05.030Test; Weber-Schoendorfer C, Schaefer C. The safety of cetirizine during pregnancy. A prospective observational cohort study. Reprod Toxicol. 2008;26(1):19–23. doi: https://doi.org/10.1016/j.reprotox.2008.05.053Test; Østensen M, Lockshin M, Doria A, et al. Update on safety during pregnancy of biological agents and some immunosuppressive anti-rheumatic drugs. Rheumatology (Oxford). 2008;47 Suppl 3:iii28–iii31. doi: https://doi.org/10.1093/rheumatology/ken168Test; Golembesky A, Cooney M, Boev R, et al. Safety of cetirizine in pregnancy. J Obstet Gynaecol. 2018;38(7):940–945. doi: https://doi.org/10.1080/01443615.2018.1441271Test; Schwarz EB, Moretti ME, Nayak S, Koren G. Risk of hypospadias in offspring of women using loratadine during pregnancy: a systematic review and meta-analysis. Drug Saf. 2008;31(9):775–788. doi: https://doi.org/10.2165/00002018-200831090-00006Test; Namazy J, Cabana MD, Scheuerle AE, et al. The Xolair Pregnancy Registry (EXPECT): the safety of omalizumab use during pregnancy. J Allergy Clin Immunol. 2015;135(2):407–412. doi: https://doi.org/10.1016/j.jaci.2014.08.025Test; González-Medina M, Curto-Barredo L, Labrador-Horrillo M, Giménez-Arnau A. Omalizumab use during pregnancy for chronic spontaneous urticaria (CSU): report of two cases. J Eur Acad Dermatol Venereol. 2017;31(5):e245–e246. doi: https://doi.org/10.1111/jdv.14034Test; Ghazanfar MN, Thomsen SF. Successful and Safe Treatment of Chronic Spontaneous Urticaria with Omalizumab in a Woman during Two Consecutive Pregnancies. Case Rep Med. 2015;2015:368053. doi: https://doi.org/10.1155/2015/368053Test; Namazy JA, Blais L, Andrews EB, et al. Pregnancy outcomes in the omalizumab pregnancy registry and a disease-matched comparator cohort. J Allergy Clin Immunol. 2020;145(2):528–536.e1. doi: https://doi.org/10.1016/j.jaci.2019.05.019Test; Ramsey-Goldman R, Schilling E. Immunosuppressive drug use during pregnancy. Rheum Dis Clin North Am. 1997;23(1):149–167. doi: https://doi.org/10.1016/s0889-857xTest(05)70320-3; Bar Oz B, Hackman R, Einarson T, Koren G. Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis. Transplantation. 2001;71(8):1051–1055. doi: https://doi.org/10.1097/00007890-200104270-00006Test; Paziana K, Del Monaco M, Cardonick E, et al. Ciclosporin use during pregnancy. Drug Saf. 2013;36(5):279–294. doi: https://doi.org/10.1007/s40264-013-0034-xTest; Sánchez-Borges M, Ansotegui IJ, Baiardini I, et al. The challenges of chronic urticaria part 2: Pharmacological treatment, chronic inducible urticaria, urticaria in special situations. World Allergy Organ J. 2021;14(6):100546. doi: https://doi.org/10.1016/j.waojou.2021.100546Test; Hacard F, Martin C, Verdu V, et al. Therapeutic patient education improves knowledge and skills for patients with chronic spontaneous urticaria. Eur J Dermatol. 2018;28(6):823–827. doi: https://doi.org/10.1684/ejd.2018.3442Test; Friedman AJ, Cosby R, Boyko S, et al. Effective teaching strategies and methods of delivery for patient education: a systematic review and practice guideline recommendations. J Cancer Educ. 2011;26(1):12–21. doi: https://doi.org/10.1007/s13187-010-0183-xTest; Rooney MK, Santiago G, Perni S, et al. Readability of Patient Education Materials From High-Impact Medical Journals: A 20-Year Analysis. J Patient Exp. 2021;8:2374373521998847. doi: https://doi.org/10.1177/2374373521998847Test; Konstantinou GN, Konstantinou GN. Psychiatric comorbidity in chronic urticaria patients: a systematic review and meta-analysis. Clin Transl Allergy. 2019;9:42. doi: https://doi.org/10.1186/s13601-019-0278-3Test; Медицинские противопоказания к проведению профилактических прививок препаратами национального календаря прививок: методические указания. — М.: Федеральный центр госсанэпиднадзора Минздрава России; 2002. — 16 с.; Nebiolo F, Bergia R, Bommarito L, et al. Effect of arterial hypertension on chronic urticaria duration. Ann Allergy Asthma Immunol. 2009;103(5):407–410. doi: https://doi.org/10.1016/S1081-1206Test(10)60360-2; Kulthanan K, Jiamton S, Thumpimukvatana N, Pinkaew S. Chronic idiopathic urticaria: prevalence and clinical course. J Dermatol. 2007;34(5):294–301. doi: https://doi.org/10.1111/j.1346-8138.2007.00276.xTest; Kozel MM, Mekkes JR, Bossuyt PM, Bos JD. Natural course of physical and chronic urticaria and angioedema in 220 patients. J Am Acad Dermatol. 2001;45(3):387–391. doi: https://doi.org/10.1067/mjd.2001.116217Test; Hiragun M, Hiragun T, Mihara S, et al. Prognosis of chronic spontaneous urticaria in 117 patients not controlled by a standard dose of antihistamine. Allergy. 2013;68(2):229–235. doi: https://doi.org/10.1111/all.12078Test; Cortellazzo Wiel L, Conversano E, Giangreco M, et al. Natural history and predictors of recovery in children with chronic spontaneous urticaria. Pediatr Allergy Immunol. 2021;32(1):201–204. doi: https://doi.org/10.1111/pai.13299Test; Özyılmaz-Bozat G, Şahiner ÜM, Buyuktiryaki B, et al. Children with chronic spontaneous urticaria: Recurrence after remission and its predictors. J Allergy Clin Immunol Pract. 2020;8(2):796–798.e1. doi: https://doi.org/10.1016/j.jaip.2019.08.010Test; Van der Valk PG, Moret G, Kiemeney LA. The natural history of chronic urticaria and angioedema in patients visiting a tertiary referral centre. Br J Dermatol. 2002;146(1):110–113. doi: https://doi.org/10.1046/j.1365-2133.2002.04582.xTest; https://www.pedpharma.ru/jour/article/view/2359Test

الإتاحة: https://doi.org/10.15690/pf.v20i5.2629Test
https://doi.org/10.1111/all.15090Test
https://doi.org/10.3389/fimmu.2019.00627Test
https://doi.org/10.3389/fimmu.2018.00689Test
https://doi.org/10.1016/j.jaci.2016.08.050Test
https://doi.org/10.1016/j.jaci.2006.09.035Test
https://doi.org/10.1111/j.1365-2222.2005.02212.xTest
https://doi.org/10.1016/j.jaci.2006.07.022Test
https://doi.org/10.1111/jdv.13198Test
https://doi.org/10.1186/1939-4551-7-31Test

View record in BASE

10

On the issue of diagnosis and treatment of skin pseudolymphoma on the example of a clinical case

المؤلفون: Olga Yu. Olisova, Elena S. Snarskaya, Natalya P. Teplyuk, Vladimir A. Varshavsky, Evgeniya S. Zolotareva, William Makhmudi

المصدر: Russian Journal of Skin and Venereal Diseases. 26:105-118

مصطلحات موضوعية: Applied Mathematics, General Mathematics

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::a881ff03d3c0739fc0dd9f6760304bfdTest
https://doi.org/10.17816/dv217710Test

تنقيح النتائج